Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2011-12-08 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GUILLESTRE (05600), Hautes-Alpes
SELARL PHARMACIE DU GUIL : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU GUIL is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GUILLESTRE (05600),
this company of category PME
shows in 2023 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU GUIL (SIREN 538395161)
Indicator
2025
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 905 157 €
2 661 362 €
2 430 352 €
2 252 349 €
2 253 144 €
N/C
2 143 275 €
Net income
216 132 €
191 944 €
227 401 €
200 314 €
157 854 €
178 481 €
149 877 €
172 176 €
141 433 €
EBITDA
N/C
N/C
253 597 €
251 917 €
195 366 €
216 076 €
216 449 €
N/C
243 712 €
Net margin
N/C
N/C
7.8%
7.5%
6.5%
7.9%
6.7%
N/C
6.6%
Revenue and income statement
In 2025, SELARL PHARMACIE DU GUIL generates positive net income of 216 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 141 k€ -> 216 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
216 132 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 24%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 71%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
24.255%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
71.184%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU GUIL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Debt ratio
0.0
161.869
294.956
203.936
152.329
106.903
53.98
38.003
24.255
Financial autonomy
26.831
33.654
22.477
29.794
35.235
42.062
57.468
63.685
71.184
Repayment capacity
0.0
None
10.898
8.236
8.485
5.759
3.778
None
None
Cash flow / Revenue
7.227%
None%
6.59%
7.993%
6.537%
7.569%
7.854%
None%
None%
Sector positioning
Debt ratio
24.252025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-11 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE DU GUIL (24.25) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
71.18%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+12 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE DU GUIL (71.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
3.78 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of SELARL PHARMACIE DU GUIL (3.78) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 233.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
233.357
Liquidity indicators evolution SELARL PHARMACIE DU GUIL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Liquidity ratio
158.137
122.602
141.781
169.685
166.54
157.32
228.884
224.042
233.357
Interest coverage
23.424
None
27.69
9.986
9.96
6.87
5.077
None
None
Sector positioning
Liquidity ratio
233.362025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good
In 2025, the liquidity ratio of SELARL PHARMACIE DU GUIL (233.36) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
5.08x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of SELARL PHARMACIE DU GUIL (5.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DU GUIL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
2025
Operating WCR
229 523 €
0 €
266 975 €
212 487 €
253 972 €
191 991 €
348 415 €
0 €
0 €
Inventory turnover (days)
28
0
30
29
28
22
24
0
0
Customer payment term (days)
1
0
3
2
2
1
2
0
0
Supplier payment term (days)
44
0
43
33
40
42
40
0
0
Positioning of SELARL PHARMACIE DU GUIL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DU GUIL is estimated at
3 433 282 €
(range 2 329 841€ - 5 387 293€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2329k€3433k€5387k€
3 433 282 €Range: 2 329 841€ - 5 387 293€
NAF 5 année 2025
Valuation method used
Net Income Multiple
216 132 €
×
15.9x
=3 433 283 €
Range: 2 329 842€ - 5 387 293€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU GUIL with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU GUIL
What is the revenue of SELARL PHARMACIE DU GUIL ?
The revenue of SELARL PHARMACIE DU GUIL in 2023 is 2.9 M€.
Is SELARL PHARMACIE DU GUIL profitable?
Yes, SELARL PHARMACIE DU GUIL generated a net profit of 216 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DU GUIL ?
The headquarters of SELARL PHARMACIE DU GUIL is located in GUILLESTRE (05600), in the department Hautes-Alpes.
Where to find the tax return of SELARL PHARMACIE DU GUIL ?
The tax return of SELARL PHARMACIE DU GUIL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU GUIL operate?
SELARL PHARMACIE DU GUIL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart